AI MARKET SCANNING

Axsome Therapeutics, Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP -1.61%
MAX GAP RECORD -13.23%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $AXSM
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 10, 2026 Earnings Release 2026-08-10 (UNDETERMINED)
+0.00%
May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN)
+1.07%
Feb 23, 2026 Earnings Release 2026-02-23 (BEFORE OPEN)
-3.97%
Nov 03, 2025 Earnings Release 2025-11-03 (BEFORE OPEN)
-8.22%
Aug 04, 2025 Earnings Release 2025-08-04 (BEFORE OPEN)
+4.83%
May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN)
-0.63%
Feb 18, 2025 Earnings Release 2025-02-18 (BEFORE OPEN)
+0.00%
Nov 12, 2024 Earnings Release 2024-11-12 (BEFORE OPEN)
+4.42%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.6%
Bullish Gaps (4)
Bearish Gaps (4)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $AXSM

EXECUTIONS2 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-30 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1464m +8.82%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗